Mark Beucler - Net Worth and Insider Trading

Mark Beucler Net Worth

The estimated net worth of Mark Beucler is at least $240 dollars as of 2024-05-12. Mark Beucler is the VP Finance of aTyr Pharma Inc and owns about 142 shares of aTyr Pharma Inc (LIFE) stock worth over $240. Details can be seen in Mark Beucler's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark Beucler has not made any transactions after 2004-05-05 and currently still holds the listed stock(s).

Transaction Summary of Mark Beucler

To

Mark Beucler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Beucler owns 1 companies in total, including Haemonetics Corp (HAE) .

Click here to see the complete history of Mark Beucler’s form 4 insider trades.

Insider Ownership Summary of Mark Beucler

Ticker Comapny Transaction Date Type of Owner
HAE Haemonetics Corp 2008-05-01 other: VP & GMGlobal Distrib Chan Mng

Mark Beucler Latest Holdings Summary

Mark Beucler currently owns a total of 1 stock. Mark Beucler owns 142 shares of aTyr Pharma Inc (LIFE) as of May 5, 2004, with a value of $240.

Latest Holdings of Mark Beucler

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LIFE aTyr Pharma Inc 2004-05-05 142 1.69 240

Holding Weightings of Mark Beucler


Mark Beucler Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Beucler has made a total of 0 transactions in aTyr Pharma Inc (LIFE) over the past 5 years. The most-recent trade in aTyr Pharma Inc is the sale of 155 shares on May 5, 2004, which brought Mark Beucler around $43,945.

Insider Trading History of Mark Beucler

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Beucler Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Beucler Ownership Network

Ownership Network List of Mark Beucler

No Data

Ownership Network Relation of Mark Beucler


Mark Beucler Owned Company Details

What does Haemonetics Corp do?

Who are the key executives at Haemonetics Corp?

Mark Beucler is the other: VP & GMGlobal Distrib Chan Mng of Haemonetics Corp. Other key executives at Haemonetics Corp include EVP & Chief Technology Officer Anila Lingamneni , President & Global Hospital Stewart W Strong , and EVP & Global Manufacturing Josep Llorens .

Haemonetics Corp (HAE) Insider Trades Summary

Over the past 18 months, Mark Beucler made no insider transaction in Haemonetics Corp (HAE). Other recent insider transactions involving Haemonetics Corp (HAE) include a net sale of 6,914 shares made by Anila Lingamneni , a net sale of 7,319 shares made by Josep Llorens , and a net sale of 2,766 shares made by Stewart W Strong .

In summary, during the past 3 months, insiders sold 2,305 shares of Haemonetics Corp (HAE) in total and bought 0 shares, with a net sale of 2,305 shares. During the past 18 months, 27,214 shares of Haemonetics Corp (HAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 27,214 shares.

Haemonetics Corp (HAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Haemonetics Corp Insider Transactions

No Available Data

Mark Beucler Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Beucler. You might contact Mark Beucler via mailing address: C/o Lifeline System 111 Lawerence Street, Framingham Ma 01702.

Discussions on Mark Beucler

No discussions yet.